Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth

· 2007 · Obstetrics & Gynecology

Abstract

BACKGROUND: Respiratory distress syndrome (RDS) is a serious complication of preterm birth and the primary cause of early neonatal mortality and disability. OBJECTIVE: To assess the effects on fetal and neonatal morbidity and mortality, on maternal mortality and morbidity, and on the child in later life of administering corticosteroids to the mother before anticipated preterm birth. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group Trials Register (October 30, 2005). SELECTION CRITERIA: Randomized controlled comparisons of antenatal corticosteroid administration (betamethasone, dexamethasone, or hydrocortisone) with placebo or with no treatment given to women with a singleton or multiple pregnancy, expected to deliver preterm as a result of either spontaneous preterm labor, preterm prelabor rupture of the membranes, or elective preterm delivery. DATA COLLECTION AND ANALYSIS: Two review authors assessed trial quality and extracted data independently. MAIN RESULTS: Twenty-one studies (3,885 women and 4,269 infants) are included. Treatment with antenatal corticosteroids does not increase risk to the mother of death, chorioamnionitis, or puerperal sepsis. Treatment with antenatal corticosteroids is associated with an overall reduction in neonatal death (relative risk [RR] 0.69, 95% confidence interval [CI] 0.58–0.81, 18 studies, 3,956 infants), RDS (RR 0.66, 95% CI 0.59–0.73, 21 studies, 4,038 infants), cerebroventricular hemorrhage (RR 0.54, 95% CI 0.43–0.69, 13 studies, 2,872 infants), necrotizing enterocolitis (RR 0.46, 95% CI 0.29–0.74, eight studies, 1,675 infants), respiratory support, intensive care admissions (RR 0.80, 95% CI 0.65–0.99, two studies, 277 infants), and systemic infections in the first 48 hours of life (RR 0.56, 95% CI 0.38–0.85, five studies, 1,319 infants). Antenatal corticosteroid use is effective in women with premature rupture of membranes and pregnancy-related hypertension syndromes. REVIEWERS' CONCLUSION: The evidence from this new review supports the continued use of a single course of antenatal corticosteroids to accelerate fetal lung maturation in women at risk of preterm birth. A single course of antenatal corticosteroids should be considered routine for preterm delivery with few exceptions. Further information is required concerning optimal dose-to-delivery interval, optimal corticosteroid to use, and effects in multiple pregnancies and to confirm the long-term effects into adulthood.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.aog.0000251610.51286.b1

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 260

Metadata

Venue
Obstetrics & Gynecology
Published
2007-01
Volume
109
Issue
1
Pages
189-190
ISSN
0029-7844 (ISSN-L)
OpenAlex
W296211136
Cited by
260
References
2
FWCI
7.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth. https://app.cochat.ai/papers/10.1097/01.aog.0000251610.51286.b1
The paper
Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth. (2007). Obstetrics & Gynecology. https://doi.org/10.1097/01.aog.0000251610.51286.b1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.